Dark Forest Capital Management’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-146,001
| Closed | -$432K | – | 938 |
|
|
2024
Q2 | $432K | Buy |
146,001
+45,721
| +46% | +$135K | 0.08% | 306 |
|
|
2024
Q1 | $454K | Buy |
100,280
+89,790
| +856% | +$407K | 0.08% | 313 |
|
|
2023
Q4 | $59.9K | Sell |
10,490
-268,128
| -96% | -$1.53M | 0.01% | 419 |
|
|
2023
Q3 | $1.28M | Buy |
278,618
+185,606
| +200% | +$854K | 0.1% | 311 |
|
|
2023
Q2 | $601K | Buy |
93,012
+77,822
| +512% | +$503K | 0.06% | 558 |
|
|
2023
Q1 | $115K | Buy |
15,190
+13,677
| +904% | +$103K | 0.03% | 612 |
|
|
2022
Q4 | $15.3K | Buy |
1,513
+1,229
| +433% | +$12.5K | ﹤0.01% | 638 |
|
|
2022
Q3 | $3K | Sell |
284
-1,985
| -87% | -$21K | ﹤0.01% | 957 |
|
|
2022
Q2 | $24K | Sell |
2,269
-8,809
| -80% | -$93.2K | 0.01% | 459 |
|
|
2022
Q1 | $108K | Buy |
11,078
+7,894
| +248% | +$77K | 0.03% | 482 |
|
|
2021
Q4 | $46K | Buy |
+3,184
| New | +$46K | 0.02% | 467 |
|
|
2021
Q3 | – | Sell |
-157
| Closed | -$3K | – | 1222 |
|
|
2021
Q2 | $3K | Buy |
+157
| New | +$3K | ﹤0.01% | 729 |
|